Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $43.0K | $0.00 | $2.49M | $6.04M | $4.05M | $4.41M |
| Revenue growth | — | — | — | — | — | -100.0% | — | 142.6% | -32.8% | 8.8% |
| Operating income | -$30.3M | -$24.9M | -$16.1M | -$14.2M | -$21.3M | -$58.0M | -$89.1M | -$65.5M | -$54.8M | -$62.9M |
| Operating margin | — | — | — | — | -49500.0% | — | -3580.0% | -1085.7% | -1350.4% | -1425.7% |
| Net income | -$16.2M | -$26.4M | -$18.2M | -$20.2M | -$21.8M | -$58.4M | -$86.8M | -$63.1M | -$54.1M | -$67.8M |
| Net margin | — | — | — | — | -50748.8% | — | -3488.9% | -1045.0% | -1333.0% | -1537.4% |
| EPS (diluted) | -$2.18 | -$0.99 | -$0.79 | -$1.46 | -$0.31 | -$0.30 | -$0.40 | -$0.26 | — | — |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$25.7M | -$23.0M | -$11.6M | -$16.9M | -$14.7M | -$47.9M | -$60.1M | -$62.1M | -$42.1M | -$57.0M |
| Capital expenditures | $320K | $276K | $77.4K | $30.0K | $307K | $939K | $4.46M | $10.5M | $3.38M | $185K |
| Free cash flow | -$26.1M | -$23.3M | -$11.7M | -$16.9M | -$15.0M | -$48.9M | -$64.5M | -$72.5M | -$45.5M | -$57.1M |
| Share buybacks | — | — | $0.00 | $48.0K | $0.00 | $0.00 | — | — | — | — |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $31.9M | $6.30M | $1.78M | $7.59M | $24.2M | $95.1M | $77.6M | $39.5M | $58.8M | $18.9M |
| Total assets | $36.1M | $11.0M | $2.45M | $16.8M | $27.4M | $106M | $142M | $64.5M | $82.4M | $43.5M |
| Total liabilities | $22.5M | $22.3M | $15.2M | $5.79M | $5.83M | $9.94M | $16.2M | $24.0M | $52.8M | $55.7M |
| Long-term debt | — | — | $1.02M | $1.07M | $1.82M | $1.71M | $1.73M | $2.80M | $27.3M | $27.5M |
| Shareholders' equity | $13.6M | $4.43M | -$12.7M | $11.0M | $21.6M | $91.2M | $74.0M | $40.6M | $29.6M | -$12.2M |
| Retained earnings | -$182M | -$208M | $31.2M | -$51.5M | -$73.3M | -$132M | -$155M | -$286M | -$340M | -$408M |
| Shares (wtd avg diluted) | 20.6M | 24.6M | 4.96M | 52.6M | 184M | 199M | 222M | 257M | 291M | 312M |
Every figure is extracted from Ocugen, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.